How to Decide Exactly Where to Get Fillers and Botox
Your forehead isn't the only spot you can get an injectable. Here's what you need to know about filler and Botox injection sites — both well-established and newly available, according to Shape.
Your forehead isn't the only spot you can get an injectable. Here's what you need to know about filler and Botox injection sites — both well-established and newly available, according to Shape.
Allergan Aesthetics presented new research at AMWC 2026 indicating a shift toward subtle, natural-looking outcomes in hyaluronic acid injectables and emphasizing the role of personalized treatment approaches.
Expanded clearance allows the system to support hair removal and vascular lesion treatment using multiple wavelength configurations.
A principal investigator discusses new randomized, controlled data on VYC-12L, a hyaluronic acid injectable, studied for reducing transverse neck lines and improving overall neck appearance, with implications for non-surgical neck rejuvenation in aesthetic practice.
Read MoreThe agency has accepted the resubmission seeking approval of the neuromodulator for the temporary improvement of moderate-to-severe glabellar lines and crow’s feet in adults.
Read MoreTwo new clinical analyses examine how simultaneous, on-label 64-unit onabotulinumtoxinA treatment of the upper face delivers natural-looking, durable, and predictable outcomes across diverse patient populations and multiple treatment cycles.
Read MoreNine e-posters showcase efficacy and safety data for botulinum neurotoxin serotype E and onabotulinumtoxinA treatments.
Read MoreAustralia’s drug regulator says counterfeit Botox vials—made to appear as Allergan products—continue to be imported despite a previous warning.
Read MoreThe approval covers cheek augmentation and age-related midface contour deficiencies, supported by phase III clinical trial data.
Read MoreThe AAFPRS is warning patients about the health dangers of counterfeit neuromodulators following FDA actions against companies selling unauthorized botulinum toxin products.
Read MoreA new analysis points to aging patients, rising med-spa volume, and next-generation HA and biostimulatory formulas as drivers behind the projected jump to an $8.45B global fillers market.
Read MoreA new report reveals shifting forces behind the rising use of hyaluronic acid fillers worldwide.
Read MorePresentations highlight investigational trenibotulinumtoxinE in the treatment of glabellar lines and other new findings across the company’s portfolio.
Read MoreThe FDA issued 18 warning letters to online sellers of unapproved and misbranded botulinum toxin products linked to serious safety risks.
Read MorePivotal trial data showed sustained improvement in chin projection and high patient and investigator satisfaction through 12 months.
Read MoreThe syringe redesign will first be available with select Belotero products in Europe before a phased international launch.
Read MoreThe study reports that many patients do not receive proper consent forms, information on complications, or aftercare instructions.
Read MoreResearch shows objective metrics from 3D scans align with patient-reported improvements, providing a clearer picture of immediate and long-term filler results.
Read More